Previous 10 |
Pfizer 's (NYSE: PFE) long-awaited deal is finally done. Last week, the big drugmaker completed its merger of Upjohn with Mylan. The transaction created a new entity, Viatris (NASDAQ: VTRS) , that's a leader in branded and generic drugs and biosimilars. If you owned Pfiz...
Viatris Inc. Announces FDA Tentative Approval of a Pediatric Formulation of Dolutegravir (DTG) Under PEPFAR Tentative approval will help enhance access to WHO-recommended pediatric medicine and reduce the cost of HIV treatment for children in low- and middle-income countries ...
The fund has managed to recover most of its losses after the COVID-19 pandemic related global market sell-off earlier this year. High-Dividend stocks might become an interesting asset class, once investors shift away their focus from stay-at-home economy. VYM has been successful s...
John Paulson’s 13F portfolio value increased from $3.13B to $3.21B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and SPDR Gold ETF. The stake in Endo International plc was increased substantially during the quarter. ...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 29, 2024 / Health systems can only function with health workers. One of the greatest global hurdles in achieving equitable access to treatment and promoting good health is the growing gap in supply and demand for healthcare workers. Patient needs are increasin...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...